Skip to main content

Table 3 EDSS scores in the study group in each time intervals

From: The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study

Time intervals Paired difference t df Sig (2-tailed)
Mean Standard deviation 95% confidence interval
1–12 1.48 1.36 0.84, 2.11 4.84 19 < 0.001
2–12 1.48 1.34 0.85, 2.10 4.91 19 < 0.001
3–12 1.48 1.15 0.94, 2.01 5.72 19 < 0.001
4–12 1.28 1.04 0.79, 2.76 5.46 19 0.001
5–12 1.13 1.02 0.65, 2.60 4.91 19 0.016
6–12 0.98 0.98 0.52, 1.43 4.45 19 0.016
7–12 0.88 0.90 0.45, 1.30 4.34 19 0.006
8–12 0.65 0.71 0.32, 0.98 4.10 19 0.088
9–12 0.58 0.71 0.24, 0.91 3.61 19 0.601
10–12 0.35 0.59 0.08, 0.62 3.67 19 0.083
11–12 0.15 0.33 0.00, 0.30 2.04 19 0.032